Description
A Phase Ib Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-sensitive Ovarian Cancer
Location: CPMC (San Francisco)
For more information please contact: ClinicalResearch@sutterhealth.org about study Roche YO40482
View study details on ClinicalTrials.gov
Principal Investigator
Co-Investigator(s)
Start Date
February 01, 2019